JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sayeed-Shah, U
Right arrow Articles by Cohn, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sayeed-Shah, U
Right arrow Articles by Cohn, L.

The Journal of Thoracic and Cardiovascular Surgery, Vol 116, 763-769, Copyright © 1998 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

NOTE: Fulltext is available only in pdf format

Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization

U Sayeed-Shah, MJ Mann, J Martin, S Grachev, S Reimold, R Laurence, V Dzau and LH Cohn
Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

INTRODUCTION: Transmyocardial laser revascularization is believed to induce an angiogenic response within ischemic myocardium. We evaluated transgene expression in the setting of transmyocardial laser revascularization and hypothesized that intramyocardial injection of plasmid DNA encoding the gene for vascular endothelial growth factor could enhance the revascularization achieved by transmyocardial laser revascularization, resulting in improved cardiac function. METHODS: Ten Yorkshire pigs had carbon dioxide-transmyocardial laser revascularization or acupuncture sites with injections of an expression plasmid encoding the gene for beta-galactosidase with or without HVJ- liposomes. Three days after transduction, transgene expression was determined by enzyme-linked immunosorbent assay. Six weeks after placement of a constrictor on the left circumflex artery, 29 pigs were randomized to ischemic controls (n = 5), transmyocardial laser revascularization (n = 4), transmyocardial laser revascularization with expression plasmid beta-galactosidase injections (n = 5), expression plasmid-vascular endothelial growth factor injections (n = 4), or transmyocardial laser revascularization with expression plasmid- vascular endothelial growth factor (n = 5) and harvested 6 weeks after therapy. Six transmyocardial laser revascularization pigs had either expression plasmid beta-galactosidase or expression plasmid-vascular endothelial growth factor injections and were harvested at 2 weeks. Normal pigs (n = 5) were included for comparison. Left ventricular free wall motion was assessed by a cardiologist in a blinded manner. RESULTS: Transgene expression did not vary significantly with or without HVJ-liposomes in transfected transmyocardial laser revascularization myocardium. However, expression was detected in 56 of 60 (93%) transmyocardial laser revascularization-transfected sites, but in only 10 of 20 (50%) non-transmyocardial laser revascularization sites (P < .001). All (5 of 5 hearts) of the transmyocardial laser revascularization-vascular endothelial growth factor treated hearts displayed no evidence of wall motion abnormalities. Only these hearts had a statistically significantly different rate of wall motion abnormality compared with ischemic controls (P = .004). CONCLUSION: Transfection efficiency was improved with the use of transmyocardial laser revascularization. Wall motion abnormalities were completely reversed within 6 weeks after transmyocardial laser revascularization with the direct injection of an expression plasmid encoding vascular endothelial growth factor.


This article has been cited by other articles:


Home page
Card Surg AdultHome page
K. A. Horvath and Y. Zhou
Transmyocardial Laser Revascularization and Extravascular Angiogenetic Techniques to Increase Myocardial Blood Flow
Card. Surg. Adult, January 1, 2008; 3(2008): 733 - 752.
[Full Text]


Home page
ICVTSHome page
T. Attmann, C. Heilmann, M. Siepe, J. Martin, F. Jentzmik, P. von Samson, F. Beyersdorf, and G. Lutter
Transgenic and transmural revascularization: regional myocardial tissue pressure during chronic ischemia
Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 138 - 144.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. C. Hughes, M. J. Post, M. Simons, and B. H. Annex
Translational Physiology: Porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis
J Appl Physiol, May 1, 2003; 94(5): 1689 - 1701.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. A.U. Heilmann, T. Attmann, P. von Samson, H. Gobel, D. Marme, F. Beyersdorf, and G. Lutter
Transmyocardial laser revascularization combined with vascular endothelial growth factor121 (VEGF121) gene therapy for chronic myocardial ischemia - do the effects really add up?
Eur. J. Cardiothorac. Surg., January 1, 2003; 23(1): 74 - 80.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
M. Ruel, R. A. Kelly, and F. W. Sellke
Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy
Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750.
[Full Text]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Lutter, T. Attmann, C. Heilmann, P. von Samson, B. von Specht, and F. Beyersdorf
The combined use of transmyocardial laser revascularization (TMLR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts
Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 753 - 761.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Huikeshoven, J. F. Beek, J. A.P. van der Sloot, R. Tukkie, J. van der Meulen, and M. J.C. van Gemert
35 years of experimental research in transmyocardial revascularization: what have we learned?
Ann. Thorac. Surg., September 1, 2002; 74(3): 956 - 970.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. Meerkin, M. Pellerin, H. T. Aretz, P. Paiement, S. L. Houser, and R. Bonan
Transmyocardial coil implants: a novel approach to transmyocardial revascularization
Ann. Thorac. Surg., August 1, 2002; 74(2): 488 - 492.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R Tabibiazar and S.G Rockson
Angiogenesis and the ischaemic heart
Eur. Heart J., June 1, 2001; 22(11): 903 - 918.
[PDF]


Home page
Cardiovasc ResHome page
H.K. Hammond and M.D. McKirnan
Angiogenic gene therapy for heart disease: a review of animal studies and clinical trials
Cardiovasc Res, February 16, 2001; 49(3): 561 - 567.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Fuchs and R. Kornowski
Transepicardial or transendocardial injury: controversies regarding angiogenic potential and mechanism of action
Cardiovasc Res, February 16, 2001; 49(3): 582 - 587.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. J. Dzau, M. J. Mann, A. Ehsan, and D. P. Griese
Gene therapy and genomic strategies for cardiovascular surgery: The emerging field of surgiomics
J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0206 - 216.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. Y. Lee, M. F. O'Hara, E. B. Finnin, R. Hachamovitch, M. Szulc, P. D. Kligfield, P. M. Okin, O. W. Isom, and T. K. Rosengart
Transmyocardial laser revascularization with excimer laser: clinical results at 1 year
Ann. Thorac. Surg., August 1, 2000; 70(2): 498 - 503.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. S. Martin, U. Sayeed-Shah, J. G. Byrne, M. H.D. Danton, K. Q. Flores, R. G. Laurence, and L. H. Cohn
Excimer versus carbon dioxide transmyocardial laser revascularization: effects on regional left ventricular function and perfusion
Ann. Thorac. Surg., June 1, 2000; 69(6): 1811 - 1816.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. A. Horvath, E. Chiu, D. C. Maun, J. W. Lomasney, R. Greene, W. H. Pearce, and D. A. Fullerton
Up-regulation of vascular endothelial growth factor mrna and angiogenesis after transmyocardial laser revascularization
Ann. Thorac. Surg., September 1, 1999; 68(3): 825 - 829.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sayeed-Shah, U
Right arrow Articles by Cohn, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sayeed-Shah, U
Right arrow Articles by Cohn, L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS